On Thursday, Shares of Great Basin Scientific Inc (NASDAQ:GBSN), lost -11.33% to $0.0900.
Great Basin Scientific, declared recently that it has retained Roth Capital Partners as financial advisor to assist in a restructuring of the Company’s Series C Warrants. The Series C Warrants were issued as part of the Unit offering the Company accomplished on March 2, 2015. The Company is also preparing to file a proxy statement and hold a special shareholder meeting to seek approval to effect a reverse stock split and authorize additional common shares to meet its obligation to deliver common shares under the cashless exercise provision of the Series C Warrants.
“While the recent Series C Warrant exercises have put our stock under greater than predictable pressure, we remain on plan for our 2015 aims of securing 170 to 180 customers and four FDA-cleared products,” said Ryan Ashton, president and CEO. “We are utilizing the funds raised in March to expand our R&D team, which will fast-track 2016 menu development and product commercialization. Further, we have doubled the size of our sales team to accelerate customer acquisition in Q4 of 2015 and the first half of 2016.”
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially accessible test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA).
Shares of Cemex SAB de CV (ADR) (NYSE:CX), inclined 0.43% to $7.02, during its last trading session.
CEMEX, declared recently the winners of “INTEGRATE your ideas”, the company’s Global Sourcing Suppliers Innovation Program. From a pool of 22 international participants, CEMEX selected three ideas mainly for their innovation, potential financial contribution to the company’s operations, ease of implementation, and degree of scalability in different countries.
The ideas presented by suppliers were critically examined through a two-stage assessment. First, 53 Global Procurement executives and Procurement country heads conducted an in-depth review of the concepts presented. Second, a group of 20 experts from several areas across CEMEX performed a thorough analysis of the projected solutions.
CEMEX, S.A.B. de C.V. (CEMEX) is an operating and holding company engaged, directly or indirectly, through its operating auxiliaries, primarily in the production, distribution, marketing and sale of cement, ready-mix concrete, aggregates, clinker and other construction materials throughout the world, and that provides construction-related services to customers and communities in more than 50 countries throughout the world.
Shares of Paypal Holdings Inc (NASDAQ:PYPL), inclined 1.42% to $31.48, during its last trading session.
Paypal Holdings, declared that it received notice of an unsolicited “mini-tender” offer by TRC Capital Corporation (TRC) to purchase up to 3 million shares of PayPal’s common stock at a price of $32.80 per share in cash. The offering price is 4.6 percent below the closing price per share of PayPal’s common stock on September 9, 2015, the last trading day before the offer was commenced. The offer is for about 0.25 percent of the outstanding shares of PayPal’s common stock.
PayPal does not endorse TRC Capital’s unsolicited mini-tender offer and recommends that shareholders do not tender their shares. PayPal is not associated with TRC Capital, its mini-tender offer or the mini-tender offer documentation.
PayPal Holdings, Inc. (PayPal) is a technology platform company, which enables digital and mobile payments on behalf of consumers and merchants around the world. The Company focuses on its consumers, merchants, friends and family to access and move their money through its platform using various devices, such as mobile, tablets, personal computers and wearables.
Finally, Delta Air Lines, Inc. (NYSE:DAL), ended its last trade with 1.20% gain, and closed at $45.41.
Delta Air Lines’ annual “Breast Cancer One” employee survivor flight takes flight recently, kicking off the airline’s month-long campaign to generate awareness and raise funds for the Breast Cancer Research Foundation. This year marks Delta’s 11th annual survivor flight, which will carry more than 140 employee breast cancer survivors on board Delta’s newly painted pink plane on the flight’s first international route from New York City to Mexico City.
The employee survivors, together with Delta leaders and BCRF executives, will travel from New York City’s John F. Kennedy International Airport to the Mexico City International Airport. Survivors will be celebrated and honored during a gatehouse event in New York and an event in Aeromexico’s hangar in Mexico City.
Colleagues from Delta’s partner airline Aeromexico will also take part in this experience, showcasing the international scope of the effort to end breast cancer.
Delta Air Lines, Inc. (Delta) provides planned air transportation for passengers and cargo throughout the United States and around the world. The Company’s route network is centered on a system of hub and international gateway airports that it operates in Amsterdam, Atlanta, Detroit, Los Angeles, Minneapolis-St. Paul, New York-LaGuardia, New York-JFK, Paris-Charles de Gaulle, Salt Lake City, Seattle and Tokyo-Narita.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.